AETNA INC /PA/ | 2013 | FY | 3


The stock option, SAR and PSAR transactions during 2013, 2012 and 2011 were as follows:
(Millions, except exercise price and remaining life)
Number of Stock
Options, SARs and PSARs

 
Weighted Average
Exercise Price

Weighted
Average Remaining
Contractual Life

Aggregate
Intrinsic
Value

 
 
 
 
 
 
2011
 
 
 
 
 
Outstanding, beginning of year
37.8

 
$
31.01

4.1

$
232.9

Granted
.1

 
36.87



Exercised
(10.0
)
 
17.35


228.8

Expired or forfeited
(1.6
)
 
47.95



Outstanding, end of year
26.3

 
$
35.18

4.0

$
246.3

 
 
 
 
 
 
Exercisable, end of year
24.7

 
$
35.38

3.8

$
230.6

 
 
 
 
 
 
2012
 
 
 
 
 
Outstanding, beginning of year
26.3

 
$
35.18

4.0

$
246.3

Granted
.1

 
44.79



Exercised
(6.7
)
 
22.73


148.0

Expired or forfeited
(.3
)
 
43.02



Outstanding, end of year
19.4

 
$
39.34

3.5

$
163.8

 
 
 
 
 
 
Exercisable, end of year
19.4

 
$
39.34

3.5

$
163.8

 
 
 
 
 
 
2013
 
 
 
 
 
Outstanding, beginning of year
19.4

 
$
39.34

3.5

$
163.8

Granted
.7

(1) 
63.32



Exercised
(9.3
)
 
36.58


203.4

Expired or forfeited
(.3
)
 
47.11



Outstanding, end of year
10.5

 
$
43.27

3.5

$
264.6

 
 
 
 
 
 
Exercisable, end of year
9.8

 
$
41.77

3.0

$
261.6

 
 
 
 
 
 

(1)  
PSARs are included in this table at the maximum amount that could potentially vest.

us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock